Device Trial Radar · NCT04840797
HeartStart HS1 Defibrillator* Event Registry
Last checked: Nov 19, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,400
Planned (sponsor's estimate)
Start
Feb 25, 2021
Primary completion
Dec 31, 2030
Study completion Dec 31, 2030
Sponsor
- Lead sponsor
- Heartstream US LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 12, 2021
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Prospective study on the performance and safety of the HeartStart OnSite (Model M5066A) \& HeartStart Home (Model M5068A) Defibrillator device data.
Conditions
- Sudden Cardiac Arrest
Interventions
HeartStart HS1Device
Automated External Defibrillator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean shock energy delivered in the pediatric populationTime frame: Up to 15 minutes during device placement
- Mean shock energy delivered in the adult populationTime frame: Up to 15 minutes during device placement
- The Patient Analysis System (PAS) shock advisory algorithm performance as determined by evaluation of the ECG as aligned with the device advisement.Time frame: Up to 15 minutes during device placement
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Philips
Pittsburgh, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.